Healthcare - Biotechnology - NASDAQ - US
$ 1.125
-7.02 %
$ 37.6 M
Market Cap
-0.85
P/E
CASH FLOW STATEMENT
-19 M
OPERATING CASH FLOW
0
INVESTING CASH FLOW
7.79 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Reviva Pharmaceuticals Holdings, Inc.
| Net Income | -24.3 M |
| Depreciation & Amortization | 195 K |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 177 K |
| Change in Working Capital | 5.01 M |
| Others | 2.19 M |
| Free Cash Flow | -19 M |
Cash Flow
Millions
| Dec-2022 | Dec-2021 | Dec-2020 | Feb-2020 | |
|---|---|---|---|---|
| OPERATING CASH FLOW | ||||
| Net Income | (24.3) | (8.5) | (3.8) | (0.8) |
| Depreciation & Amortization | 0 | 0 | 591 | 645 |
| Deferred Income Tax | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 0.2 | 0.1 | 0 | 0 |
| Other Operating Activities | 0.2 | (1.6) | 2.4 | 6.41 K |
| Change in Working Capital | 5.0 | (0.7) | (2.3) | 0.6 |
| Cash From Operations | (19.0) | (10.7) | (3.7) | (0.2) |
| INVESTING CASH FLOW | ||||
| Capital Expenditures | 0 | 0 | 0 | 0 |
| Other Items | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | 0 | 0 | 0 | 0 |
| FINANCING CASH FLOW | ||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Other Financing Activities | 19 K | 98.5 K | 12.8 | 0 |
| Cash From Financing Activities | 7.8 | 31.6 | 12.8 | 100 K |
| CHANGE IN CASH | ||||
| Net Change In Cash | (11.2) | 20.9 | 8.8 | (0.1) |
| FREE CASH FLOW | ||||
| Free Cash Flow | (19.0) | (10.7) | (3.7) | (0.2) |